|Articles|August 20, 1997

Imation completes Cemax-Icon buy

Imation of Oakdale, MN, last week closed its acquisition of PACS Cemax-Icon of Fremont, CA. Imation and Cemax-Icon announced the agreement in May, in which Imation agreed to pay $30 million up front and up to $49 million in milestone payments for

Imation of Oakdale, MN, last week closed its acquisition of PACS Cemax-Icon of Fremont, CA. Imation and Cemax-Icon announced the agreement in May, in which Imation agreed to pay $30 million up front and up to $49 million in milestone payments for Cemax-Icon (SCAN 5/28/97).

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Subscribe Now!

Latest CME

Video

Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | Texas

Jeremie Calais, MD, PhD; Qian Qin, MD

Imation completes Cemax-Icon buy

Newsletter

Related Content

A Closer Look at Automated LLM Protocoling for Abdominal and Pelvic CT

FDA Clears Multimodality Tumor Marker for Breast Cancer Imaging

Mammography Study Reveals Limitations with DBT in Women with Extremely Dense Breasts

Challenges with Diversity and Residency Attrition Rates in Interventional Radiology

Breast MRI Study Suggests Black Women Are 31 Percent More Likely to Have High BPE

Latest CME

Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | Texas

Inaugural Brain & Spine Metastases Conference: Evolving Practice and Emerging Therapies

2nd Annual Hawaii Cancer Conference

23rd Annual Winter Lung Cancer Conference®

43rd Annual Miami Breast Cancer Conference®

19th Annual New York GU Cancers Congress™

Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies

Cases and Conversations™: Redefining Treatment Pathways in Low-Grade Serous Ovarian Cancer

Cases & Conversations™: Expert Perspectives on Leveraging Recent Advances to Transform SCLC Treatment

Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma

17th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™

(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice

PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC—Expert Perspectives on New Approvals and Emerging Strategies

Radioligand Therapy 101: The Science Behind the Strategy

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

BURST CME™ Resource Center: Integrating Novel PSMA-Directed Radioligand Approaches for Diagnosis and Management of Prostate Cancer

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

2026 International Symposium of Gastrointestinal Oncology (ISGIO)

26th Annual International Lung Cancer Congress

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

44th Annual CFS®: Innovative Cancer Therapy for Tomorrow™

21st Annual New York Lung Cancers Symposium®

9th Annual School of Nursing Oncology™

Trending on Diagnostic Imaging

FDA Clears Multimodality Tumor Marker for Breast Cancer Imaging

A Closer Look at Automated LLM Protocoling for Abdominal and Pelvic CT

Mammography Study Reveals Limitations with DBT in Women with Extremely Dense Breasts

FDA Clears AI Software for Opportunistic Multisystem Computed Tomography Screening

Breast MRI Study Suggests Black Women Are 31 Percent More Likely to Have High BPE